Dynamic Immune-Nutritional Indices as Powerful Predictors of Pathological Complete Response in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy.

Background/Objectives: Pathological complete response (pCR) is an established surrogate marker of neoadjuvant chemotherapy (NACT) efficacy in breast cancer; however, reliable predictors of pCR remain limited. Immune-inflammation- and nutrition-based…

Preview only. Read the full abstract at the source